WBC
RDY icon

Westpac Banking Corp’s Dr. Reddy's Laboratories RDY Stock Holding History

Westpac Banking Corp’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-74,400
Closed -$762K – 854
2016
Q2 		$762K Buy
+74,400
New +$682K 0.01% 641

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westpac Banking Corp's RDY Position: Q3 2016 in Review

Westpac Banking Corp sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 74,400 shares — an estimated $762K sold.

Westpac Banking Corp first reported a position in RDY in Q2 2016 and held it in 1 quarter. The position peaked at $762K in Q2 2016. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • Westpac Banking Corp reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
  • Westpac Banking Corp sold 74,400 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $762K.
  • Westpac Banking Corp first reported a position in Dr. Reddy's Laboratories in Q2 2016 and held it in 1 quarter.
  • Westpac Banking Corp's Dr. Reddy's Laboratories position peaked at $762K in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Westpac Banking Corp's 13F filing for Q3 2016, filed 10 Nov 2016.